Novartis India Ltd — Updates, 27-05-2025: Company Update

Novartis India Limited has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, confirming full adherence to applicable SEBI regulations and company policies. The report highlights no director disqualifications, no material subsidiaries, and proper evaluation of board and committee performance. All related party transactions received prior Audit Committee approval. There were no SEBI or stock exchange actions against the company or its promoters, and no resignation of statutory auditors during the period. Compliance with disclosure requirements and insider trading regulations has been maintained, with no significant deviations or observations reported.